Aktien in diesem Artikel
Indizes in diesem Artikel
For Immediate ReleaseChicago, IL – September 21, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple
Inc. AAPL, Thermo Fisher Scientific Inc. TMO, Royal Dutch Shell
plc (RDS.A), Microsoft
Corporation MSFT and The Estée Lauder Companies Inc. EL.Here are highlights from Monday’s Analyst Blog:Top Analyst Reports for Apple, Thermo Fisher and Royal Dutch ShellThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple, Thermo Fisher, and Royal Dutch Shell. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Shares of Apple have modestly underperformed the S&P 500 over the past year (+33.5% vs. +38.9%), but things have been improving for the tech giant lately. The Zacks analyst believes that the company has been benefiting from momentum in the Services business, strong adoption of Apple Pay and growing Apple Music subscriber base.Apple’s near-term prospects remain bright and are driven by new iPhones that support 5G, revamped iPad and Mac line-up of devices, as well as an expanding App Store ecosystem. The company’s ability to attract small developers has been a key catalyst. Foreign exchange woes, lower than expected growth in the Services segment and supply constraints have been limiting the company’s growth though.(You can read the full research report on Apple here >>>)Thermo Fisher shares have gained +31.4% in the last six months against the Zacks Medical Instruments industry’s gain of +16.6%. The Zacks analyst believes that several takeovers such as the Advanced Bioprocessing buyout from BD and Patheon have been expanding the company’s growth profile. Thermo Fisher experienced strong end market growth in the second quarter, driven by robust fundamentals in the life sciences, and strong pandemic response. The company also raised 2021 guidance, which buoys optimism. Unfavorable macroeconomic conditions, a competitive landscape and currency fluctuations remain major headwinds though.(You can read the full research report on Thermo Fisher here >>>)Shares of Royal Dutch Shell have gained +0.9% in the past three months against the Zacks International Integrated Oil industry’s fall of -2.8%. The Zacks analyst believes that Royal Dutch Shell is poised for capital appreciation based on a slew of tailwinds. The BG acquisition has made Shell the largest liquefied natural gas producer in the world.Shell’s announcement of the launch of a $2 billion stock buyback program reflects its steadily improving earnings. It is also making solid progress toward the transition to a renewable energy-focused future. The company is, however, facing some headwinds on the production front, which is evident from the amount of hydrocarbon it pumped in the first half. Its dismal reserve replacement ratio might restrict its production growth potential.(You can read the full research report on Royal Dutch Shell here >>>)Other noteworthy reports we are featuring today include Microsoft and The Estée Lauder Companies.Media ContactZacks Investment Research800-767-3771 ext. firstname.lastname@example.org https://www.zacks.com Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.5 Stocks Set to Double Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Apple Inc. (AAPL): Free Stock Analysis Report Microsoft Corporation (MSFT): Free Stock Analysis Report Royal Dutch Shell PLC (RDS.A): Free Stock Analysis Report Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis Report The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment ResearchWeiter zum vollständigen Artikel bei "Zacks"